highly improbable, but some patients have exhibited recurrence. patients with low-grade lesions can remain asymptomatic after surgery and show recurrence 1–2 years in follow-up sessions. however, since residual tissue size is a large determinant for profiling recurrence, it is almost never the case that a low-grade astroblastoma continues to appear in size and strength after the second resection. usually, patients are not recommended for resection at all and are simply directed towards other therapeutic techniques. most children can continue to lead productive, healthy lives after a low-grade astroblastoma is treated. high-grade surviving the symptoms of high-grade astroblastoma is not life-threatening, but a significant portion of patients die due to repeated recurrence of tumors as they continue to grow and spread. unlike conventional low-grade tumors, high-grade tumors associate a plethora of factors when they metastasize to other areas of the body. therefore, complications frequently occur after surgery is performed since an oncologist cannot efficiently control the tumor in a suitable time-frame. cases in literature confirm that high-grade patients face up to five or six resection surgeries and still experience symptoms post-operatively. the dual-action of chemotherapy and radiotherapy can slow down recurrence when gross total resection is performed multiple times, but there is no guarantee that the tumor will ever be in remission. onsiderations for specialized astroblastoma therapies, but they are not mentioned in current literature. epidemiology astroblastoma predominantly affects children, but young adults are also susceptible to the tumor . although the tumor is widely considered a pediatric disease, elderly patients are documented throughout literature. age incidence the age distribution of astroblastoma is largely bimodal, suggesting that two distinct diagnosis peaks occur from ages 5–10 and ages 21–30. a likely explanation for this discrepancy is that parents of children are more likely to report symptoms of nausea and constant headaches than young adults, who may, at first, disregard these symptoms for a lesser condition. nevertheless, a combination of age, anatomic location, and image assessment can efficiently evaluate astroblastoma. furthermore, the age of a patient can aid an oncologist in recommending appropriate treatment plans, along with other factors. gender incidence in reported cases of the tumor over the last 25 years, the number of affected females with astroblastoma is significantly higher than the number of affected males. sughrue et al. confirmed this trend, stating that 70% of the cases with clearly stated gender were female (100 cases total). while several publications support a genetic predisposition to females, the underlying reasons are still unknown. environmental incidence at this point, no literature has indicated whether environmental factors increase the likelihood of astroblastoma. although cancer in general is caused by a variety of external factors, including carcinogens, dangerous chemicals, and viral infections, astroblastoma research has not even attempted to classify incidence in this regard. the next few decades will aid in this understanding.